WO2021173865A3 - Compounds for detection of viral pathogens - Google Patents

Compounds for detection of viral pathogens Download PDF

Info

Publication number
WO2021173865A3
WO2021173865A3 PCT/US2021/019720 US2021019720W WO2021173865A3 WO 2021173865 A3 WO2021173865 A3 WO 2021173865A3 US 2021019720 W US2021019720 W US 2021019720W WO 2021173865 A3 WO2021173865 A3 WO 2021173865A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
detection
viral pathogens
pathogens
viral
Prior art date
Application number
PCT/US2021/019720
Other languages
French (fr)
Other versions
WO2021173865A2 (en
Inventor
Satish C. AGRAWAL
Prakash Rai
Michael P. Filosa
Peter Tzuyu WEN
Robb J. Osinski
Michael G. Horner
Original Assignee
Bambu Vault Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bambu Vault Llc filed Critical Bambu Vault Llc
Publication of WO2021173865A2 publication Critical patent/WO2021173865A2/en
Publication of WO2021173865A3 publication Critical patent/WO2021173865A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus

Abstract

The disclosure provides compositions and methods of use thereof to detect pathogenic viruses like coronavirus.
PCT/US2021/019720 2020-02-25 2021-02-25 Compounds for detection of viral pathogens WO2021173865A2 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US202062981408P 2020-02-25 2020-02-25
US62/981,408 2020-02-25
US202063012779P 2020-04-20 2020-04-20
US63/012,779 2020-04-20
US202063014476P 2020-04-23 2020-04-23
US63/014,476 2020-04-23
US202063035438P 2020-06-05 2020-06-05
US63/035,438 2020-06-05
US202063037239P 2020-06-10 2020-06-10
US63/037,239 2020-06-10

Publications (2)

Publication Number Publication Date
WO2021173865A2 WO2021173865A2 (en) 2021-09-02
WO2021173865A3 true WO2021173865A3 (en) 2021-10-21

Family

ID=77490213

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/019720 WO2021173865A2 (en) 2020-02-25 2021-02-25 Compounds for detection of viral pathogens

Country Status (1)

Country Link
WO (1) WO2021173865A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023219136A1 (en) * 2022-05-12 2023-11-16 国立大学法人 東京大学 Fluorescent probe for detecting peptide-linked hydrolase
CN117604067A (en) * 2022-05-20 2024-02-27 张玥 Novel coronavirus detection method, detection card, detection kit and protective mask
CN116621939B (en) * 2023-05-17 2024-01-19 吉林农业大学 Application of antibacterial peptide LRGG in preparation of fluoroquinolone antibacterial synergist

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065091A1 (en) * 2003-08-18 2011-03-17 Van Der Hoek Cornelia Maria Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics
US20130296186A1 (en) * 1997-10-06 2013-11-07 Trustees Of Tufts College, Tufts University Self-encoding sensor with microspheres
US20160231324A1 (en) * 2013-09-24 2016-08-11 The Regents Of The University Of California Encapsulated sensors and sensing systems for bioassays and diagnostics and methods for making and using them
US20180059117A1 (en) * 2006-10-06 2018-03-01 Sirigen Inc. Fluorescent methods and materials for directed biomarker signal amplification

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130296186A1 (en) * 1997-10-06 2013-11-07 Trustees Of Tufts College, Tufts University Self-encoding sensor with microspheres
US20110065091A1 (en) * 2003-08-18 2011-03-17 Van Der Hoek Cornelia Maria Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics
US20180059117A1 (en) * 2006-10-06 2018-03-01 Sirigen Inc. Fluorescent methods and materials for directed biomarker signal amplification
US20160231324A1 (en) * 2013-09-24 2016-08-11 The Regents Of The University Of California Encapsulated sensors and sensing systems for bioassays and diagnostics and methods for making and using them

Also Published As

Publication number Publication date
WO2021173865A2 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
WO2021173865A3 (en) Compounds for detection of viral pathogens
MX2018009633A (en) Inhibitor of indoleamine-2,3-dioxygenase (ido).
WO2017181141A3 (en) Combinations and methods comprising a capsid assembly inhibitor
WO2016149484A3 (en) Compositions and methods for specific reactivation of hiv latent reservoir
TW200833662A (en) 4,5-ring annulated indole derivatives and methods of use thereof
BRPI0720569B8 (en) substituted tetracycline compounds and use of said compounds for the treatment of a bacterial, viral or parasitic infection
WO2013074386A3 (en) Hcv ns3 protease inhibitors
CL2008003819A1 (en) Compounds derived from substituted 2-ketoamino benzoic acid, inhibitors of the hepatitis c virus; pharmaceutical composition; and its use in the treatment of HCV infection.
GB2503066A8 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
MY161495A (en) Virus like particle compositions and methods of use
WO2007041487A3 (en) Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family
MX341842B (en) Influenza viruses able to infect canids, uses thereof.
EA200970916A1 (en) COMPOUNDS 5,6-DIGIDRO-1N-PYRIDIN-2-SHE
WO2007120374A3 (en) Anti-arenaviral compounds
WO2010055164A3 (en) Isoquinolone derivatives as inhibitors of plavivirus replication
TW200738700A (en) HIV integrase inhibitors
WO2018158306A8 (en) Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
WO2016119052A8 (en) Compositions and methods for enhancing oncolytic virus efficacy
WO2016100615A3 (en) Methods and composition for neutralization of influenza
BR112015022261A2 (en) non-oriented electric steel sheet which has excellent high frequency iron loss properties
WO2017161133A8 (en) N-hydroxyisoquinolinedione inhibitors of hbv replication
WO2009008921A3 (en) Influenza b viruses with reduced sensitivity to neuraminidase inhibitors
WO2018075633A3 (en) Compositions and methods for detecting or quantifying hepatitis c virus
MX2022016281A (en) Broad spectrum antiviral compositions and methods.
MA40805A (en) LONG-ACTION PHARMACEUTICAL COMPOSITIONS AGAINST HEPATITIS C

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21761619

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21761619

Country of ref document: EP

Kind code of ref document: A2